Nihon Kohden (OTCMKTS:NHNKY) Shares Gap Up – What’s Next?

Nihon Kohden Corporation (OTCMKTS:NHNKY) shares gapped up prior to trading on Tuesday . The stock had previously closed at $9.05, but opened at $9.4499. Nihon Kohden shares last traded at $9.4499, with a volume of 219 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised Nihon Kohden to a “hold” rating in a report on Monday, April 27th. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Buy”.

Nihon Kohden Stock Performance

The stock has a market capitalization of $1.57 billion, a P/E ratio of 15.89 and a beta of 0.39. The company’s fifty day simple moving average is $8.95 and its two-hundred day simple moving average is $10.00.

Nihon Kohden (OTCMKTS:NHNKY) last issued its quarterly earnings data on Thursday, May 14th. The company reported $0.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.24 by $0.10. Nihon Kohden had a return on equity of 9.46% and a net margin of 6.08%.The company had revenue of $453.10 million during the quarter, compared to analysts’ expectations of $414.40 million. On average, research analysts predict that Nihon Kohden Corporation will post 0.6 earnings per share for the current fiscal year.

Nihon Kohden Company Profile

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.